DETROIT–(BUSINESS WIRE)– #NextGenHealthcare–NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced Anthony Palladino as Chief Financial Officer. Palladino joins NextGen Healthcare from Thoma Bravo, where he served as an operating partner, working alongside portfolio company leadership teams to strengthen financial operations, improve operating efficiency and accelerate profitable growth across the firm’s software portfolio. Prior to Thoma Bravo, Palladi

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner Roche announced today late-breaking oral presentation data from the ongoing Phase 3 IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 – 52.0, P<0.0001), relative to placebo at 37 wee

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today late-breaking oral presentation data from the ongoing Phase III IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 – 52.0, P<0.0001), relat

HOUSTON–(BUSINESS WIRE)–Building on decades of holding pharmaceutical companies responsible for dangerous products and unlawful business practices, The Lanier Law Firm played a pivotal role supporting Texas Attorney General Ken Paxton in securing a $45 million settlement with Gilead Sciences, Inc. Announced on Oct. 22, the settlement resolves claims that the company offered illegal incentives to medical providers to prescribe its drugs over competitors’ medications. In many cases, these presc

LOS ANGELES–(BUSINESS WIRE)–Investors in Bank Of America Corporation (“Bank of America” or the “Company”) (NYSE: BAC) have until December 15, 2026 to ask the Court to appoint them lead plaintiff in a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired Bank Of America Corporation securities between August 1, 2025 and October 13, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP (“Glancy”) today reminded investors of the upcoming deadline.

WASHINGTON–(BUSINESS WIRE)–Lyntris Inc. (NYSE: LYNX), a defense technology company delivering integrated sensing, communications, and mission systems, today announced it will issue financial results for the third quarter fiscal year 2026 on Wednesday, November 4, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 PM Eastern Time. Hosting the call and webcast will be Brian Morrison, CEO; Matt Alty, President and Vice Chair; Tim Paulin, CFO; and N

BENSALEM, Pa.–(BUSINESS WIRE)–Millrose Properties, Inc. (“Millrose” or the “Company”) (NYSE: MRP) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 8, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company’s securities from February 7, 2025 through October 2, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Rubenstsein et al. v.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.